SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 54.03 |
| Book Value / Share | 0.53 |
| Price / Book | n/a |
| NCAV ($M) | 29.74 |
| NCAV / Share | 0.29 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.66 |
| Return on Assets (ROA) | -0.56 |
| Return on Equity (ROE) | -0.73 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.22 |
| Current Ratio | 2.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 68.76 |
| Assets | 93.06 |
| Liabilities | 39.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Braidwell Lp | 9.99 | 5.36 | |
| 13G/A | Venrock Healthcare Capital Partners II, L.P. | 9.99 | 2.67 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| CVSI – CV Sciences, Inc. | CYAN – Cyanotech Corporation |
| CYDY – CytoDyn Inc. | DMKPQ – DMK Pharmaceuticals Corporation |
| DRNK – NOHO, Inc. |
Financial data and stock pages provided by
Fintel.io